TOP 10 COMPANIES IN NEWBORN SCREENING MARKET
|
|
The
Newborn Screening Market, projecting a
Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2030. The market is
expected to reach $2.49 billion by 2030, driven by factors such as the
increasing prevalence of congenital heart diseases and genetic disorders, a
rising neonatal population, and growing awareness regarding the importance of
newborn screening.
Market Dynamics and Challenges
While
the Newborn Screening Market is poised for significant expansion, certain
challenges could hinder its growth. The shortage of healthcare professionals
and the advent of non-invasive prenatal screening technologies are identified
as potential constraints. However, the market is expected to benefit from
government programs, legislation promoting newborn screening, and
opportunities arising in emerging economies.
Top 10 Companies Shaping the Newborn Screening Market: https://meticulousblog.org/top-10-companies-in-newborn-screening-market/
Meticulous
Research® highlights the top 10 companies playing pivotal roles in shaping the
Newborn Screening Market:
1.
Thermo Fisher Scientific Inc. (U.S.) - A global company
offering products and services across various sectors, operating in the
newborn screening market through the Life Sciences Solutions segment.
2.
ARCHIMED Group (France) - A global investment firm specializing
in healthcare industry transactions, focusing on small-cap and mid-cap buyout
transactions.
3.
PerkinElmer, Inc. (U.S.) - A multinational company providing
products, solutions, and services for the life sciences, diagnostics, and
applied markets, operating in the newborn screening market through the
Diagnostics business segment.
4.
Medtronic plc (Ireland) - A healthcare technology company
operating in the newborn screening market through the Medical Surgical
Portfolio segment, offering biomedical engineering products.
5.
Trivitron Healthcare Pvt Ltd. (India) - A medical
technology company with a global presence in over 180 countries, manufacturing
and distributing medical technology products.
6.
Bio-Rad Laboratories, Inc. (U.S.) - A distributor and
manufacturer of clinical diagnostics products and life science research,
operating in the newborn screening market through the Clinical Diagnostics
segment.
7.
Demant A/S (Denmark) - A hearing healthcare and audio
technology group providing hearing care and diagnoses for hearing disorders,
operating in the newborn screening market through the Hearing Healthcare
segment.
8.
Baebies, Inc. (U.S.) - A medical technology company utilizing
digital microfluidics to commercialize products for early disease detection
and comprehensive diagnostic solutions.
9.
ZenTech s.a. (Belgium) - A biotechnology company specializing
in In Vitro Diagnostics (IVD) and Radio Isotopic Assays (RIA) for prenatal,
neonatal, and pediatric use.
10.
Hoffmann-La Roche Ltd (Switzerland) - A pharmaceutical
and diagnostics company operating in the newborn screening market through the
Diagnostics segment, offering differentiated medicines and in vitro
diagnostics.
Download Free Sample
Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5367
Meticulous Research® Insights
Meticulous
Research®'s latest publication predicts a noteworthy growth of 7.9% in the
Newborn Screening Market during the forecast period of 2023-2030. The
comprehensive report provides detailed insights into the financial
performance, key products, company strategies, partnerships, and acquisitions
of these industry leaders.
About Meticulous Research®
Meticulous
Research® is a leading provider of market intelligence and advisory services,
committed to delivering high-quality insights and strategic business solutions
globally. With a meticulous approach to research and analysis, the firm aims
to provide valuable information for decision-making and business growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment